To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa

Investigative Site 403, Berlin

Investigative Site 026, The Bronx

Investigative Site 007, Hershey

Investigative Site 703, Granada

Investigative Site 017, Winston-Salem

Investigative Site 008, Chapel Hill

Investigative Site 702, Madrid

Investigative Site 016, Atlanta

Investigative Site 015, Coral Gables

Investigative Site 021, Miami

Investigative Site 006, Tampa

Investigative Site 001, Tampa

Investigative Site 005, Hoover

Investigative Site 304, Nantes

Investigative Site 401, Bochum

Investigative Site 701, Valencia

Investigative Site 002, West Lafayette

Investigative Site 004, Fort Gratiot

Investigative Site 402, Frankfurt am Main

Investigative Site 019, St Louis

Investigative Site 023, New Orleans

Investigative Site 027, Baton Rouge

Investigative Site 018, Bellaire

Investigative Site 011, Phoenix

Investigative Site 003, Gilbert

Investigative Site 404, Erlangen

Investigative Site 022, Newbury Park

Investigative Site 012, Huntington Beach

Investigative Site 014, Fountain Valley

Investigative Site 010, Fremont

Investigative Site 009, Sacramento

Investigative Site 025, Cromwell

Investigative Site 013, Boston

Investigative Site 101, Calgary

Investigative Site 102, Calgary

Investigative Site 405, Dessau

Investigative Site 406, Dresden

Investigative Site 552, Rzeszów

Investigative Site 551, Wroclaw

Investigative Site 553, Wroclaw